Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Mon, 09/26/22 - 11:25 pm
Tags:
Inflation Reduction Act
,
Joe Biden
,
Novo Nordisk
,
Gilead Sciences
,
Bristol Myers Squibb
,
AstraZeneca
,
drug pricing
Gilead completes acquisition of MiroBio in $405m cash deal
PM Live
Wed, 09/21/22 - 10:29 am
Tags:
Gilead Sciences
,
M&A
,
MiroBio
,
autoimmune disease
Gilead's Yescarta eyes first to move up lymphoma ladder in Europe amid busy week at EMA
Fierce Pharma
Mon, 09/19/22 - 09:12 am
Tags:
Gilead Sciences
,
Yescarta
,
Europe
,
diffuse large B-cell lymphoma
,
high-grade B-cell lymphoma
ESMO: Gilead's Trodelvy makes surprise comeback with above-par breast cancer survival showing
Fierce Pharma
Wed, 09/7/22 - 11:59 pm
Tags:
Gilead Sciences
,
Trodelvy
,
ESMO
,
HR-positive HER-negative breast cancer
,
breast cancer
Brace for an end-of-year boost to drug approvals
EP Vantage
Fri, 09/2/22 - 12:14 pm
Tags:
FDA
,
drug approvals
,
Alnylam Pharmaceuticals
,
Apellis Pharmaceuticals
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
Mirati Therapeutics
,
Moderna Therapeutics
,
Provention Bio
,
Roche
,
TG Therapeutics
,
Travere Therapeutics
Gilead hits back at Bristol Myers' Supreme Court petition in CAR-T patent feud
Fierce Pharma
Sun, 08/28/22 - 10:19 pm
Tags:
Gilead Sciences
,
CAR-T
,
patents
,
Supreme Court
,
Kite Pharma
,
Bristol Myers Squibb
Gilead can't escape antitrust suit centered on pay-for-delay deal with Cipla, judge says
Fierce Pharma
Tue, 08/23/22 - 10:24 pm
Tags:
Gilead Sciences
,
Cipla
,
pay-for-delay
,
legal generics
,
Emtriva
,
Viread
After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
Fierce Pharma
Tue, 08/16/22 - 12:36 pm
Tags:
Gilead Sciences
,
Immunomedics
,
Trodelvy
,
Everest Medicines
How a small UK biotech ended up in Gilead’s hands
BioPharma Dive
Sun, 08/7/22 - 11:18 pm
Tags:
Gilead Sciences
,
MiroBio
,
M&A
,
University of Oxford
Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M
TechCrunch
Thu, 08/4/22 - 06:41 pm
Tags:
Gilead Sciences
,
M&A
,
University of Oxford
,
MiroBio
Gilead reports 'very strong quarter' despite slipping Veklury sales
Endpoints
Wed, 08/3/22 - 10:55 am
Tags:
Gilead Sciences
,
earnings
,
Biktarvy
Gilead again backs AlloVir's T cell therapy in $127M direct offering
Endpoints
Wed, 07/27/22 - 10:53 am
Tags:
Gilead Sciences
,
AlloVir
,
funding
,
t cell therapy
AIDS 2022 preview – Gilead shoots for an HIV cure
EP Vantage
Wed, 07/27/22 - 10:27 am
Tags:
Gilead Sciences
,
HIV
,
AIDS
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Endpoints
Thu, 07/21/22 - 10:38 am
Tags:
Pfizer
,
Gilead Sciences
,
Big Pharma
,
ulcerative colitis
,
Crohn's Disease
,
drug development
,
FDA
Gilead tries again with twice-yearly HIV drug lenacapavir
Pharmaforum
Tue, 06/28/22 - 05:52 pm
Tags:
Gilead Sciences
,
HIV
,
FDA
,
lenacapavir
Gilead nets $33M in settlement over yearslong HIV drug fraud case in Florida
Fierce Pharma
Tue, 06/28/22 - 10:41 am
Tags:
Gilead Sciences
,
HIV
,
fraud
,
Florida
,
legal
Gilead trumpets win for the chronic hepatitis delta prospect it acquired in $1B+ buyout
Fierce Pharma
Thu, 06/23/22 - 07:47 pm
Tags:
Gilead Sciences
,
hepatitis delta
,
Hepcludex
Bristol Myers Squibb takes its CAR-T patent case to US' top court in bid to revive $1.2B verdict against Gilead
Fierce Pharma
Thu, 06/16/22 - 10:48 pm
Tags:
Bristol Myers Squibb
,
Gilead Sciences
,
patents
,
CAR-T
,
Juno Therapeutics
ASCO: Gilead's Trodelvy limps forward in new breast cancer lane as below-par showing casts doubt
Fierce Pharma
Sun, 06/5/22 - 11:42 pm
Tags:
Gilead Sciences
,
Trodelvy
,
breast cancer
,
ASCO 2022
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
Tags:
ASCO 2022
,
AstraZeneca
,
Enhertu
,
Gilead Sciences
,
Trodelvy
,
Roche
,
tiragolumab
,
cancer
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.